Cargando…
A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
BACKGROUND: Acute myeloid leukemia (AML) is a common type of hematological malignancy in elderly people. Geriatricians have developed comprehensive geriatric assessment (CGA) methods for elderly patients; however, the tools used for CGA in AML are not uniform. Thus, we aimed to validate the instrume...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046252/ https://www.ncbi.nlm.nih.gov/pubmed/31934939 http://dx.doi.org/10.1097/CM9.0000000000000645 |
_version_ | 1783501930818961408 |
---|---|
author | Zhang, Chun-Li Feng, Ru Li, Jiang-Tao Wang, Ting Bai, Jie-Fei Liu, Hui |
author_facet | Zhang, Chun-Li Feng, Ru Li, Jiang-Tao Wang, Ting Bai, Jie-Fei Liu, Hui |
author_sort | Zhang, Chun-Li |
collection | PubMed |
description | BACKGROUND: Acute myeloid leukemia (AML) is a common type of hematological malignancy in elderly people. Geriatricians have developed comprehensive geriatric assessment (CGA) methods for elderly patients; however, the tools used for CGA in AML are not uniform. Thus, we aimed to validate the instrumental activities of daily living (IADL) scales, age, comorbidities (Charlson Comorbidity Index), and albumin (IACA) index, which is a new tool for CGA, in elderly patients with AML. METHODS: Patients aged ≥60 years who had been diagnosed with AML were screened for eligibility. Among the IACA low-, intermediate-, and high-risk groups, continuous variables were compared using the Mann-Whitney U test, and categorical variables were compared using χ(2) and Fisher exact tests. In addition, probabilities of overall survival (OS) were estimated using the Kaplan-Meier method. RESULTS: A total of 21, 34, and 6 patients were categorized into IACA low-risk (0 point), intermediate-risk (1–2 points), and high-risk (≥3 points) groups, respectively. The rates of relapse/progression-related mortality were 23.8%, 58.8%, and 100.0% in the IACA low-, intermediate-, and high-risk groups, respectively (χ(2) = 12.81, P < 0.001). The 2-year probabilities of OS were 47.7% (95% confidence interval [CI] 22.8%–72.6%) and 20.2% (95% CI 5.9%–34.5%) in the IACA low- and intermediate-risk groups, respectively (χ(2) = 5.99, P = 0.014), which were significantly higher than those in the high-risk group (low-risk [47.7% (95% CI 22.8%–72.6%)] vs. high-risk [0], χ(2) = 20.80, P < 0.001; intermediate-risk [20.2% (95% CI 5.9%–34.5%)] vs. high-risk [0], χ(2) = 7.56, P = 0.006; respectively). In the IACA low-risk group, the 2-year probability of OS in patients receiving induction chemotherapy (50.8% [95% CI 24.1%–77.5%]) was significantly higher than that in those receiving best supportive care (0, χ(2) = 25.74, P < 0.001). CONCLUSION: We suggest that the IACA index might be a simple and effective tool for comprehensive geriatric assessment in elderly AML patients. |
format | Online Article Text |
id | pubmed-7046252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-70462522020-03-10 A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China Zhang, Chun-Li Feng, Ru Li, Jiang-Tao Wang, Ting Bai, Jie-Fei Liu, Hui Chin Med J (Engl) Original Articles BACKGROUND: Acute myeloid leukemia (AML) is a common type of hematological malignancy in elderly people. Geriatricians have developed comprehensive geriatric assessment (CGA) methods for elderly patients; however, the tools used for CGA in AML are not uniform. Thus, we aimed to validate the instrumental activities of daily living (IADL) scales, age, comorbidities (Charlson Comorbidity Index), and albumin (IACA) index, which is a new tool for CGA, in elderly patients with AML. METHODS: Patients aged ≥60 years who had been diagnosed with AML were screened for eligibility. Among the IACA low-, intermediate-, and high-risk groups, continuous variables were compared using the Mann-Whitney U test, and categorical variables were compared using χ(2) and Fisher exact tests. In addition, probabilities of overall survival (OS) were estimated using the Kaplan-Meier method. RESULTS: A total of 21, 34, and 6 patients were categorized into IACA low-risk (0 point), intermediate-risk (1–2 points), and high-risk (≥3 points) groups, respectively. The rates of relapse/progression-related mortality were 23.8%, 58.8%, and 100.0% in the IACA low-, intermediate-, and high-risk groups, respectively (χ(2) = 12.81, P < 0.001). The 2-year probabilities of OS were 47.7% (95% confidence interval [CI] 22.8%–72.6%) and 20.2% (95% CI 5.9%–34.5%) in the IACA low- and intermediate-risk groups, respectively (χ(2) = 5.99, P = 0.014), which were significantly higher than those in the high-risk group (low-risk [47.7% (95% CI 22.8%–72.6%)] vs. high-risk [0], χ(2) = 20.80, P < 0.001; intermediate-risk [20.2% (95% CI 5.9%–34.5%)] vs. high-risk [0], χ(2) = 7.56, P = 0.006; respectively). In the IACA low-risk group, the 2-year probability of OS in patients receiving induction chemotherapy (50.8% [95% CI 24.1%–77.5%]) was significantly higher than that in those receiving best supportive care (0, χ(2) = 25.74, P < 0.001). CONCLUSION: We suggest that the IACA index might be a simple and effective tool for comprehensive geriatric assessment in elderly AML patients. Wolters Kluwer Health 2020-02-20 2020-02-20 /pmc/articles/PMC7046252/ /pubmed/31934939 http://dx.doi.org/10.1097/CM9.0000000000000645 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Original Articles Zhang, Chun-Li Feng, Ru Li, Jiang-Tao Wang, Ting Bai, Jie-Fei Liu, Hui A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
title | A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
title_full | A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
title_fullStr | A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
title_full_unstemmed | A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
title_short | A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China |
title_sort | new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from china |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046252/ https://www.ncbi.nlm.nih.gov/pubmed/31934939 http://dx.doi.org/10.1097/CM9.0000000000000645 |
work_keys_str_mv | AT zhangchunli anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT fengru anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT lijiangtao anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT wangting anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT baijiefei anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT liuhui anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT zhangchunli newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT fengru newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT lijiangtao newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT wangting newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT baijiefei newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina AT liuhui newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina |